Liu Yani, Wang KeWei
Department of Pharmacology, Qingdao University School of Pharmacy, Qingdao, China.
Handb Exp Pharmacol. 2019;260:187-205. doi: 10.1007/164_2019_333.
Ion channels are macromolecular proteins that form water-filled pores in cell membranes and they are critical for a variety of physiological and pharmacological functions. Dysfunctional ion channels can cause diseases known as channelopathies. Ion channels are encoded by approximately 400 genes, representing the second largest class of proven drug targets for therapeutic areas including neuropsychiatric disorders, cardiovascular and metabolic diseases, immunological diseases, nephrological diseases, gastrointestinal diseases, pulmonary/respiratory diseases, and many cancers. With more ion channel structures are being solved and functional robust assays are being developed, there are tremendous opportunities for identifying specific modulators targeting ion channels for new therapy.
离子通道是在细胞膜中形成充满水的孔道的大分子蛋白质,它们对于多种生理和药理功能至关重要。功能失调的离子通道可导致被称为离子通道病的疾病。离子通道由大约400个基因编码,是包括神经精神疾病、心血管和代谢疾病、免疫疾病、肾脏疾病、胃肠道疾病、肺部/呼吸系统疾病以及许多癌症在内的治疗领域中已证实的第二大类药物靶点。随着越来越多的离子通道结构得到解析以及功能强大的检测方法不断开发,识别针对离子通道的新型治疗特异性调节剂存在巨大机遇。